Global Human Coagulation Factor VIII Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5686224   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Human Coagulation Factor VIII, commonly referred to as Factor VIII or FVIII, is a crucial protein in the blood clotting cascade. Produced in the liver, Factor VIII plays a fundamental role in blood coagulation by assisting in the formation of blood clots at the site of vascular injury. In its active form, Factor VIII acts as a cofactor for Factor IX, facilitating the conversion of Factor X to its active form, Factor Xa. This process is essential for the activation of thrombin, which, in turn, converts fibrinogen into fibrin to create a stable blood clot. Deficiencies or mutations in Factor VIII can lead to hemophilia A, a hereditary bleeding disorder characterized by impaired blood clotting. Treatment for hemophilia A often involves the administration of recombinant or plasma-derived Factor VIII concentrates to restore normal clotting function and prevent excessive bleeding in affected individuals. Managing Factor VIII levels is critical in maintaining proper hemostasis and preventing bleeding episodes in individuals with hemophilia A.
According to DIResearch's in-depth investigation and research, the global Human Coagulation Factor VIII market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Human Coagulation Factor VIII. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Coagulation Factor VIII market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Coagulation Factor VIII market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Coagulation Factor VIII industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Coagulation Factor VIII Include:
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Human Coagulation Factor VIII Product Segment Include:
Recombinant Factor VIII
Plasma-derived Factor VIII
Human Coagulation Factor VIII Product Application Include:
Hemophilia A
Spontanous / Trauma
Surgical
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Human Coagulation Factor VIII Industry PESTEL Analysis
Chapter 3: Global Human Coagulation Factor VIII Industry Porter's Five Forces Analysis
Chapter 4: Global Human Coagulation Factor VIII Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Human Coagulation Factor VIII Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Human Coagulation Factor VIII Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Human Coagulation Factor VIII Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Human Coagulation Factor VIII Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Human Coagulation Factor VIII Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Human Coagulation Factor VIII Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Human Coagulation Factor VIII Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Human Coagulation Factor VIII Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Human Coagulation Factor VIII Market Overview

1.1 Product Definition and Statistical Scope

1.2 Human Coagulation Factor VIII Product by Type

1.2.1 Global Human Coagulation Factor VIII Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Recombinant Factor VIII

1.2.3 Plasma-derived Factor VIII

1.3 Human Coagulation Factor VIII Product by Application

1.3.1 Global Human Coagulation Factor VIII Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hemophilia A

1.3.3 Spontanous / Trauma

1.3.4 Surgical

1.3.5 Other

1.4 Global Human Coagulation Factor VIII Market Revenue and Sales Analysis

1.4.1 Global Human Coagulation Factor VIII Market Size Analysis (2019-2030)

1.4.2 Global Human Coagulation Factor VIII Market Sales Analysis (2019-2030)

1.4.3 Global Human Coagulation Factor VIII Market Sales Price Trend Analysis (2019-2030)

1.5 Human Coagulation Factor VIII Market Development Status and Trends

1.5.1 Human Coagulation Factor VIII Industry Development Status Analysis

1.5.2 Human Coagulation Factor VIII Industry Development Trends Analysis

2 Human Coagulation Factor VIII Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Human Coagulation Factor VIII Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Human Coagulation Factor VIII Market Analysis by Regions

4.1 Human Coagulation Factor VIII Overall Market: 2023 VS 2024 VS 2030

4.2 Global Human Coagulation Factor VIII Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Human Coagulation Factor VIII Revenue and Market Share by Region (2019-2024)

4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2025-2030)

4.3 Global Human Coagulation Factor VIII Sales and Forecast Analysis (2019-2030)

4.3.1 Global Human Coagulation Factor VIII Sales and Market Share by Region (2019-2024)

4.3.2 Global Human Coagulation Factor VIII Sales Forecast by Region (2025-2030)

4.4 Global Human Coagulation Factor VIII Sales Price Trend Analysis (2019-2030)

5 Global Human Coagulation Factor VIII Market Size by Type and Application

5.1 Global Human Coagulation Factor VIII Market Size by Type

5.1.1 Global Human Coagulation Factor VIII Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Human Coagulation Factor VIII Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Human Coagulation Factor VIII Market Size by Application

5.2.1 Global Human Coagulation Factor VIII Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Human Coagulation Factor VIII Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Human Coagulation Factor VIII Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Human Coagulation Factor VIII Market Size by Type

6.3.1 North America Human Coagulation Factor VIII Sales by Type (2019-2030)

6.3.2 North America Human Coagulation Factor VIII Revenue by Type (2019-2030)

6.4 North America Human Coagulation Factor VIII Market Size by Application

6.4.1 North America Human Coagulation Factor VIII Sales by Application (2019-2030)

6.4.2 North America Human Coagulation Factor VIII Revenue by Application (2019-2030)

6.5 North America Human Coagulation Factor VIII Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Human Coagulation Factor VIII Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Human Coagulation Factor VIII Market Size by Type

7.3.1 Europe Human Coagulation Factor VIII Sales by Type (2019-2030)

7.3.2 Europe Human Coagulation Factor VIII Revenue by Type (2019-2030)

7.4 Europe Human Coagulation Factor VIII Market Size by Application

7.4.1 Europe Human Coagulation Factor VIII Sales by Application (2019-2030)

7.4.2 ? Europe Human Coagulation Factor VIII Revenue by Application (2019-2030)

7.5 Europe Human Coagulation Factor VIII Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Human Coagulation Factor VIII Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Human Coagulation Factor VIII Market Size by Type

8.3.1 China Human Coagulation Factor VIII Sales by Type (2019-2030)

8.3.2 China Human Coagulation Factor VIII Revenue by Type (2019-2030)

8.4 China Human Coagulation Factor VIII Market Size by Application

8.4.1 China Human Coagulation Factor VIII Sales by Application (2019-2030)

8.4.2 China Human Coagulation Factor VIII Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Human Coagulation Factor VIII Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Human Coagulation Factor VIII Market Size by Type

9.3.1 APAC (excl. China) Human Coagulation Factor VIII Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Human Coagulation Factor VIII Revenue by Type (2019-2030)

9.4 APAC (excl. China) Human Coagulation Factor VIII Market Size by Application

9.4.1 APAC (excl. China) Human Coagulation Factor VIII Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Human Coagulation Factor VIII Revenue by Application (2019-2030)

9.5 APAC (excl. China) Human Coagulation Factor VIII Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Human Coagulation Factor VIII Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Human Coagulation Factor VIII Market Size by Type

10.3.1 Latin America Human Coagulation Factor VIII Sales by Type (2019-2030)

10.3.2 Latin America Human Coagulation Factor VIII Revenue by Type (2019-2030)

10.4 Latin America Human Coagulation Factor VIII Market Size by Application

10.4.1 Latin America Human Coagulation Factor VIII Sales by Application (2019-2030)

10.4.2 Latin America Human Coagulation Factor VIII Revenue by Application (2019-2030)

10.5 Latin America Human Coagulation Factor VIII Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Human Coagulation Factor VIII Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Human Coagulation Factor VIII Market Size by Type

11.3.1 Middle East & Africa Human Coagulation Factor VIII Sales by Type (2019-2030)

11.3.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Type (2019-2030)

11.4 Middle East & Africa Human Coagulation Factor VIII Market Size by Application

11.4.1 Middle East & Africa Human Coagulation Factor VIII Sales by Application (2019-2030)

11.4.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Application (2019-2030)

11.5 Middle East & Africa Human Coagulation Factor VIII Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Human Coagulation Factor VIII Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Human Coagulation Factor VIII Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Human Coagulation Factor VIII Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Human Coagulation Factor VIII Average Sales Price by Manufacturers (2020-2024)

12.2 Human Coagulation Factor VIII Competitive Landscape Analysis and Market Dynamic

12.2.1 Human Coagulation Factor VIII Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Shire (Baxter)

13.1.1 Shire (Baxter) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio

13.1.3 Shire (Baxter) Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Bayer

13.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Bayer Human Coagulation Factor VIII Product Portfolio

13.2.3 Bayer Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 CSL

13.3.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 CSL Human Coagulation Factor VIII Product Portfolio

13.3.3 CSL Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Pfizer

13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Pfizer Human Coagulation Factor VIII Product Portfolio

13.4.3 Pfizer Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Grifols

13.5.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Grifols Human Coagulation Factor VIII Product Portfolio

13.5.3 Grifols Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Biogen

13.6.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Biogen Human Coagulation Factor VIII Product Portfolio

13.6.3 Biogen Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Octapharma

13.7.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Octapharma Human Coagulation Factor VIII Product Portfolio

13.7.3 Octapharma Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 NovoNordisk

13.8.1 NovoNordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 NovoNordisk Human Coagulation Factor VIII Product Portfolio

13.8.3 NovoNordisk Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Greencross

13.9.1 Greencross Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Greencross Human Coagulation Factor VIII Product Portfolio

13.9.3 Greencross Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Kedrion

13.10.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Kedrion Human Coagulation Factor VIII Product Portfolio

13.10.3 Kedrion Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 BPL

13.11.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 BPL Human Coagulation Factor VIII Product Portfolio

13.11.3 BPL Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.12 Hualan Bio

13.12.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Hualan Bio Human Coagulation Factor VIII Product Portfolio

13.12.3 Hualan Bio Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.13 RAAS

13.13.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 RAAS Human Coagulation Factor VIII Product Portfolio

13.13.3 RAAS Human Coagulation Factor VIII Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Human Coagulation Factor VIII Industry Chain Analysis

14.2 Human Coagulation Factor VIII Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Human Coagulation Factor VIII Typical Downstream Customers

14.4 Human Coagulation Factor VIII Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support